Migdal Insurance & Financial Holdings’s Exact Sciences EXAS Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,190	Closed	-$684K	–	616
2021 Q1	$684K	Buy	5,190 +3,221	+164%	+$441K	0.01%	287
2020 Q4	$261K	Sell	1,969 -8,203	-81%	-$992K	﹤0.01%	286
2020 Q3	$1.04M	Sell	10,172 -8,814	-46%	-$761K	0.01%	284
2020 Q2	$1.65M	Buy	18,986 +6,194	+48%	+$495K	0.03%	204
2020 Q1	$742K	Sell	12,792 -535	-4%	-$43.4K	0.02%	205
2019 Q4	$1.23M	Buy	13,327 +1,849	+16%	+$163K	0.02%	198
2019 Q3	$1.04M	Buy	11,478 +3,435	+43%	+$391K	0.02%	241
2019 Q2	$949K	Buy	8,043 +2,332	+41%	+$235K	0.02%	247
2019 Q1	$495K	Buy	+5,711	New	+$486K	0.01%	301

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Migdal Insurance & Financial Holdings's EXAS Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 5,190 shares — an estimated $684K sold.

Migdal Insurance & Financial Holdings first reported a position in EXAS in Q1 2019 and held it in 9 quarters. The position peaked at $1.65M in Q2 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

Migdal Insurance & Financial Holdings reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 5,190 Exact Sciences shares in Q2 2021, an estimated $684K.
Migdal Insurance & Financial Holdings first reported a position in Exact Sciences in Q1 2019 and held it in 9 quarters.
Migdal Insurance & Financial Holdings's Exact Sciences position peaked at $1.65M in Q2 2020.
623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.